The Prospective Segeberg Registry for Mitral Transcatheter Edge-to-Edge Repair
ConditionMitral Regurgitation (MR)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorSegeberger Kliniken GmbH
About this trial
A Prospective Follow-up Assessment in Bad Segeberg for Patients with severe MR undergoing M-TEER
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with severe MR undergoing M-TEER
Disqualifiers
None
Trial population
Patients with severe MR undergoing M-TEER
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Transcatheter edge to edge repair
Devicemitral valve transcatheter edge-to-edge repair
Treatment groups
2,000 Participants
are divided into 1 treatment groupGroup A: Patients of severe MR undergoing M-TEER1 intervention
Trial outcomes
Primary outcomes
1
Rate of in-hospital and long-term cardiovascular adverse events in percent
Peri-procedural events and in-hospital cardiovascular events and long-term cardiovascular events (bleeding, peripheral and coronary vascular complication, stroke, myocardial infarction, stent thrombosis, revascularization, death, heart failure, rehospitalization)
Time frame
2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov